STING1 and cancer: Originally identified as a crucial component of the innate immune host-defense system, cGAS-STING signaling has more recently been recognized as a key pathway in the initiation and pathogenesis of inflammatory diseases, including cancer, autoimmune and neurodegenerative diseases [5].